Syringes and Needles MarketThe sales of syringes and needles in the Gulf Cooperation Council (GCC) region are expected to witness steady growth, with a projected compound annual growth rate (CAGR) of ...
The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.
After repeatedly wowing investors, Roche’s star eye med Vabysmo collected more than $4 billion in sales during its third year ...
Orocidin A/S, a subsidiary of (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in supporting Nordic and U.S. life sciences companies in establishing themselves ...
The syringe filling machine industry is experiencing significant growth due to the increasing demand for injectable medications, particularly with the rise of biologics, vaccines, and precision ...
By Teddy Rosenbluth Apoorva Mandavilli and Sheryl Gay Stolberg The Trump administration, moving quickly to clamp down on health and science agencies, has canceled a string of scientific meetings ...
The strategic competition between the United States and the People’s Republic of China (PRC) emerged prominently during Donald Trump’s first administration. Policies such as tariffs and trade ...
Esketamine is the first monotherapy for MDD with inadequate response to two oral antidepressants ... Mitigation Strategy Program to ensure safe administration in certified health care settings.
The Trump administration has ousted the Coast Guard’s top admiral, according to a message to the service’s personnel circulated Tuesday, in what could be the first of several changes to ...
This creates a significant demand for oral syringes, which ensure accurate and controlled administration, especially in regions with high COPD prevalence. The rising number of surgical procedures ...
This creates a significant demand for oral syringes, which ensure accurate and controlled administration, especially in regions with high COPD prevalence. The rising number of surgical procedures in ...